Skip to main content
. 2003 Jul;16(3):415–429. doi: 10.1128/CMR.16.3.415-429.2003

FIG. 1.

FIG. 1.

Targeting of bacterial cell wall, cell membrane components, and toxins to prevent injury. Use of nonlytic antibiotic agents may minimize the release of toxic components following initiation of antibiotic therapy. Different organisms and different bacterial substances require separate neutralizing antagonists, making a uniform strategy difficult to design.